| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/04/2001 | EP1112078A2 New use |
| 07/04/2001 | EP1112073A1 Calcilytic compounds |
| 07/04/2001 | EP1112066A2 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 07/04/2001 | EP0821689B1 Tumor protease activated prodrugs of phosphoramide mustard analogs |
| 07/04/2001 | CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation |
| 07/04/2001 | CN1302295A Synthetic methods for polyphenols |
| 07/04/2001 | CN1302287A Bioreductive cytotoxic agents |
| 07/04/2001 | CN1302209A Polyol-IFN-beta conjugates |
| 07/04/2001 | CN1301848A New polypeptide-NADH dehydrogenase subunit I-11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301771A New polypeptide-human gonadotrophin-releasing hormone 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301767A New polypeptide-human RS3 protein 13 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301766A New polypeptide-human protein hydrolase regulating protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301761A New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |
| 07/04/2001 | CN1301756A New polypeptide-myelin PO protein 14 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301745A New polypeptide-amyloid glucoprotein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301743A New polypeptide-cytochrome b 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301732A New polypeptide-thiolase protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301722A New polypeptide-heparin binding protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301717A New polypeptide-gitter protein light chain 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301713A New polypeptide-stathmin-protein 8 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301709A New polypeptide-small hydrophilic vegetable seed protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301701A Camptothecine like compound, its preparing method and medicinal composition containing them |
| 07/04/2001 | CN1301564A Cordyceps medicinal composition and its preparing method |
| 07/04/2001 | CN1301562A Taxad liquid as anti-cancer traditional chinese medicine |
| 07/04/2001 | CN1301546A Cancer curing medicine and its preparing method |
| 07/04/2001 | CN1301542A Taxad medicine wine |
| 07/04/2001 | CN1068009C Isolated nucleic acid molecules as members of the mage-XP family and uses thereof |
| 07/04/2001 | CN1068003C Mesoplatinum complex and its synthesis |
| 07/04/2001 | CN1067892C Application of theachrome in preparing potentiate and antidote for radiotherany and chemotherapy |
| 07/03/2001 | US6255517 Thymol derivatives having anti-tumor activity, and anti-cancer agent comprising the same |
| 07/03/2001 | US6255495 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups and method of application thereof |
| 07/03/2001 | US6255485 Purine inhibitors of protein kinases, G proteins and polymerases |
| 07/03/2001 | US6255472 Isolated nucleic acid molecule encoding a human skeletal muscle-specific receptor |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255456 Enzymatic polypeptide; for use in diagnosis, detection, prevention and treatment of cancer and immune defects |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255353 Inhibition of angiogenesis |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255324 Amino-and mercurio-substituted 4′,5'-dihydropsoralens and therapeutical uses thereof |
| 07/03/2001 | US6255314 Cancerous metastasis inhibitors containing uracil derivatives |
| 07/03/2001 | US6255290 Reducing sensitivity to skin cancer; topical administering of nucleotide |
| 07/03/2001 | US6255105 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/03/2001 | US6255073 Cell segment from drosophila; for the treatment of cancer, tumors, viral or retroviral infection and autoimmune diseases |
| 07/03/2001 | US6255055 Diagnosing breast cancer; evaluate breast tissue for preferential polypeptide expression, compare with expression in noncancerous tissue, an amplified presence of preferential polypeptide in tissue indicates cancer |
| 07/03/2001 | US6255046 Drug screening of enzyme inhibitors by expressing enzyme or kinase domain, purifying, isolating, adding test compound and fructose 6-phosphate, and measuring formation of fructose 2,6 bisphosphate product; reduction indicates candidate |
| 07/03/2001 | US6254868 Monoclonal antibodies |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | US6254853 Drugs with carriers |
| 07/03/2001 | CA2216231C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2328781A1 Novel antibacterial and prokinetic macrolides |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046422A1 Novel cytokine zcyto18 |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046389A2 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046253A1 A new polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046251A1 A new polypeptide- myb protein 9 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046247A1 A new polypeptide-subtilopeptidase 9 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046243A2 A new polypeptide-ring finger protein 8 and the polynucleotide encoding it |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046228A2 Nucleic acid vaccination |
| 06/28/2001 | WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046204A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | WO2001046203A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046199A1 Methods and compounds for inhibiting mrp1 |
| 06/28/2001 | WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046178A2 Substituierte bisindolymaleimide |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046172A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | WO2001046162A2 Novel 3-substituted 1,2,4-benzotriazines, a method for their production and the use thereof for the treatment and prophylaxis of tumours |
| 06/28/2001 | WO2001046157A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | WO2001046138A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | WO2001046137A1 Farnesyl transferase inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046110A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 06/28/2001 | WO2001045836A2 Molecules derived from mechanism based drug design |
| 06/28/2001 | WO2001045752A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045737A2 Herpes simplex virus-1 glycoprotein c mutants for treating unwanted hyperproliferative cell growth |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045728A2 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | WO2001045723A1 Medicines manufactured from old platycodon extracts |
| 06/28/2001 | WO2001045714A2 Formulations of adenosine a1 agonists |